PHILADELPHIA, Aug. 20, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2019 fourth quarter and full year on Tuesday, August 27, 2019, after the market closes.  Lannett management will host a conference call that same afternoon at 4:30

BOSTON, Aug. 20, 2019 /PRNewswire/ -- Pulpdent Corporation, a Boston-area dental research and manufacturing company, celebrates six years since the launch of ACTIVA BioACTIVE-RESTORATIVE. The bioactive dental filling material has been used in millions of restorations across the globe.

IRVING, Texas, Aug. 20, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today unveiled plans to develop the Caris Life Sciences Corporate Park in Irving, Texas, adding to the company's growing footprint in

BERWYN, Pa., Aug. 20, 2019 /PRNewswire/ -- Melmark, Inc. has announced the promotion of Tom Crofcheck, CPA to Vice President and Chief Financial Officer (CFO). Mr. Crofcheck will assume the role in late September from Joseph Zakrzewski, CPA, who announced his retirement earlier this year.

RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2019 /PRNewswire/ -- Marken announced today that its nursing services for home-based clinical trials are now operational in most key markets around the world, which can be integrated into its already well-established logistics network. The home healthcare offering extends its existing direct to patient logistics services. The expand

LUND, Sweden, Aug. 20, 2019 /PRNewswire/ -- BioInvent International AB's (publ) (OMXS: BINV) partner Oxurion NV has today reported topline data from a Phase lla study evaluating THR-317, a humanized antibody against placental growth factor (PlGF), in combination with anti-VEGF (ranibizumab), an anti-vascular endothelial growth factor (VEGF) antibody, for the treatme

STEVENAGE, England, Aug. 20, 2019 /PRNewswire/ -- AKL Research and Development (AKLRD), a company developing an investigational osteoarthritis (OA) medicine, today announces the appointment of Michael Martin as its Chief Financial Officer.

STOCKHOLM, Aug. 20, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announces that Klaas Bakker has been appointed as the new Chief Medical Officer (CMO) for Oncopeptides, starting in November.Johan Harmenberg has reached retirement age and as the company continues to expand its activities, Johan has decide

OSLO, Norway, Aug. 20, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces the appointment of Dr Lars Nieba as Chief Technology Officer and a member of the executive management team. Dr Nieba brings 20 years of leadership experience in the development of multiple pharmaceutical product candidates and innovative technologies. Hi

UPPSALA, Sweden, Aug. 20, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces it has entered into an exclusive agreement with GAIA AG (GAIA), a global leader in digital therapeutics that successfully launched its first digital health product in 200